Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2004, p. 8145-8153, Vol. 24, No. 18
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.18.8145-8153.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Cellular and Structural Biology,1 Department of Pathology, The University of Texas Health Science Center at San Antonio,2 Department of Biology, University of Texas at San Antonio,3 Research Division, South Texas Veteran's Health Care System, San Antonio, Texas,6 Biosciences Division, Los Alamos National Laboratories, Los Alamos, New Mexico,4 Division of Life Sciences, Lawrence Berkeley National Laboratories, Berkeley, California5
Received 8 March 2004/ Returned for modification 27 April 2004/ Accepted 26 June 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The results demonstrating a lower spontaneous mutant frequency in the male germ line led to questions about how a lower mutant frequency is realized. Mutant frequency is regulated to a large extent by mechanisms that function to monitor and guard genetic integrity. Among these genetic maintenance mechanisms are DNA repair pathways that recognize DNA damage, remove it, and restore the integrity of the DNA. The base excision repair (BER) pathway restores DNA integrity when challenged by damaged bases (e.g., oxidized or alkylated bases), abasic sites, and some single-strand breaks (29, 35, 39, 41). In this pathway, a damaged base is first recognized and removed by a DNA glycosylase, creating an apurinic/apyrimidinic site (abasic or AP site). The phosphate backbone is nicked, usually by AP endonuclease. A correct base is inserted by a DNA polymerase, the deoxyribose phosphate moiety is removed, and the phosphodiester backbone is sealed by a DNA ligase (29, 39). Several BER genes, including Apex (AP endonuclease), Polß (DNA polymerase ß), Xrcc1, and Lig3 (DNA ligase III), appear to be most abundantly expressed in the testis, or male germ cells specifically, relative to other tissues in the young adult animal (1, 9, 23, 33, 58, 61, 67). In vitro BER assays have revealed a greater activity in testis and spermatogenic cell extracts than in tested somatic cell and tissue extracts (7, 24, 42). These data are consistent with a high level of BER activity contributing to the low spontaneous mutant frequency in the male germ line observed in young adult male mice.
What then causes the increased spontaneous mutant frequency in germ cells with increased age? A significant decrease (50%) in BER activity has been observed in nuclear extracts prepared from spermatogenic cells or testis extracts obtained from old (24- to 26-month-old) mice (7, 25). The decline in in vitro BER activity observed in spermatogenic cells was accompanied by a decline in AP endonuclease (Apex) abundance in one study (25) and by a decline in DNA polymerase ß (ß-pol) in another (7). Together these data suggest that a decline in BER mediates, at least in part, the increased spontaneous mutant frequency detected in male germ cells obtained from older animals. The purpose of the studies described herein was to more directly test the ability of a diminution in Apex abundance to mediate a decline in BER that would in turn result in an increased spontaneous mutant frequency. Apex heterozygous knockout (Apex+/) mice (32) were crossed with the lacI transgenic mice, and the spontaneous mutant frequencies were determined for spermatogenic cells and select somatic tissues. The results indicate that inactivation of one Apex allele is sufficient to mediate increased spontaneous mutagenesis in germ line and somatic tissue DNA.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of mixed spermatogenic cells and somatic tissue collection. Apex+/ lacI+ and control Apex+/+ lacI+ mice were humanely euthanized with isofluorane, and then testis, liver, and spleen were collected immediately. Liver and spleen were sliced into small pieces, frozen in liquid nitrogen, and stored at 80°C until use for DNA isolation. Preparation of the mixed spermatogenic cells was conducted as described previously (4, 5). Briefly, each pair of testes was removed, decapsulated, placed in enriched Krebs ringer bicarbonate medium (EKRB), and kept on ice. Collagenase (0.5 mg/ml) and trypsin (0.5 mg/ml) treatments were performed by incubation at 33°C in 5% CO2-enriched air for 15 min, with shaking. DNase (1 µg/ml) treatment was performed subsequently. The resulting mixed spermatogenic cell suspension was passed through a pipette repeatedly to disaggregate cells, and then the cell suspension was filtered through a 100-µm-pore-size nylon cell strainer (Millipore) and centrifuged at 1,200 x g for 12 min at 4°C. The cell pellet was washed in EKRB and resuspended in fresh EKRB with gentle passage through a pipette. A minimum of 7.5 x 106 cells/ml was obtained per cell suspension. Mixed spermatogenic cells were pelleted by centrifugation, frozen by immersion in liquid nitrogen, and stored at 80°C until used for DNA isolation.
Mutant frequency determinations.
High-molecular-weight genomic DNA was isolated from the cells and tissues of interest by using the RecoverEase DNA isolation kit (Stratagene) per the manufacturer's recommendations. The
shuttle vector transgene carrying the lacI mutation reporter gene was rescued from genomic DNA samples by using Transpack packaging extracts as recommended by the manufacturer (Stratagene). Ten NZY bottom agar-containing assay trays were prepared for each sample. Each packaging reaction mixture was added to a culture of SCS-8 cells prior to being combined with agarose containing the chromogenic substrate 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal). Plates were incubated overnight at 37°C to allow plaque formation. Putative mutant plaques were identified by their blue appearance and were marked for isolation. All identified putative mutant plaques were cored and replated on fresh X-Gal/NZY plates to confirm that the lacI mutations were likely mouse derived (20, 21, 40, 43, 54). Mutant frequency was calculated by dividing the number of confirmed mutant plaques by the total number of PFU for that sample.
Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays and histology. Following euthanasia, animal body weights and testis weights were recorded for 9-month-old Apex+/+ and Apex+/ animals. Testis, spleen, and liver were removed, labeled, and rapidly submerged in formalin solution. Tissue blocks were prepared by personnel in the San Antonio Cancer Institute-sponsored histology facility housed within the Department of Pathology. One slide per animal and tissue of interest (i.e., testis, spleen, and liver) was stained with hematoxylin and eosin (H&E).
Paraffin-embedded testis cross-sections corresponding to Apex+/ and wild-type Apex+/+ mice were subjected to the terminal deoxynucleotidyl end-labeling procedure as originally described (17). Sections were deparaffinized and proteinase K treated (40 µg/ml) for 15 min at room temperature. Three percent H2O2-MeOH was used to block internal peroxidases. Slides were rinsed first in double-distilled H2O and then in terminal deoxynucleotidyl transferase (TdT) buffer (30 mM Trizma base [pH 7.2], 140 mM sodium cacodylate, 1 mM CoCl2). Slides were incubated with 195 U of TdT (Gibco, BRL)/µl and 1 U of biotinylated dUTP (Boehringer Mannheim)/µl at 37°C in a moist chamber for 2 h. After incubation, slides were placed in TB buffer (300 mM NaCl, 30 mM sodium citrate) for 5 min at room temperature and then were washed with double-distilled H2O. Two percent bovine serum albumin was applied to slides for 10 min followed by rinses in distilled H2O and phosphate-buffered saline (PBS) buffer. Incubation (37°C, 1 h) was performed with streptavidin horseradish peroxidase (Dako) diluted 1:200 in streptavidin peroxidase diluent (BioGenex). After a PBS rinse, DAB (3,3-diaminobenzidine tetrahydrochloride; Polysciences Inc.) was added (10 mg/10 ml) to automation buffer (100 mM Tris-HCl, 100 mM Tris-base [pH 7.5], 0.75% Brij 35) in conjunction with 1 µl of 30% H2O2/ml. Subsequent to rinses in distilled H2O, samples were treated with 0.2% OsO4 in PBS. The sections were counterstained with methyl green (1% in double-distilled H2O) following rinses in PBS. Sections were dehydrated prior to mounting coverslips with permount solution.
Slides thus prepared were scored with a Zeiss Photomicroscope III. The percentage of tubules containing apoptotic cells, with apoptosis defined as a TUNEL-positive signal, was determined by dividing the number of seminiferous tubule cross-sections containing at least one TUNEL-positive cell by the total number of scored tubules. TUNEL-positive cell types were identified to determine the numbers of spermatogonia and primary spermatocytes yielding a positive signal. Spermatogenic cell types were determined by cell morphology and position within the seminiferous tubule.
Statistical analysis. Body weights and testis weights were compared by using the nonparametric Wilcoxon rank sum test. Statistical analyses were performed in a manner similar to that of previously described analyses for lacI mutant frequencies (45, 60). The numbers of mutants were described by Poisson random variables, and the mutant frequencies were compared by using the conditional binomial test. The TUNEL data were analyzed by using analysis of variance, and comparisons among mean values were Bonferroni adjusted.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
Apoptotic prevalence. The percentage of seminiferous tubules with TUNEL-positive cells was similar between 3-month-old Apex+/ and Apex+/+ mice (Fig. 5). However, a significant difference was detected between 9-month-old Apex+/ and Apex+/+ mice. The number of seminiferous tubule cross-sections displaying TUNEL-positive cells was 32.8% for Apex+/ mice and 19.3% for Apex+/+ mice (P < 0.05) (Fig. 5, Table 2). Analysis of apoptotic cell types revealed a higher proportion of TUNEL-positive spermatogonia for 9-month-old Apex+/ mice than for Apex+/+ mice (39.1% versus 20.2%) (Fig. 6; Table 2) and a greater prevalence of TUNEL-positive primary spermatocytes for Apex+/ mice than for Apex+/+ control mice (54.4% versus 17.3%) at 9 months of age. There were no significant differences in the proportions of apoptotic spermatogonia and primary spermatocytes between genotypes at 3 months.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Gross measures of animal health, including body weights, testis weights, and histological analyses of spleen, liver, and testis, revealed no detectable manifestation of abnormal development or disease, with the exception of centrilobular fatty changes in the livers of several 9-month-old Apex+/ mice. Based on these assessments, the Apex+/ mice were considered normal young adults. However, examination of mutant frequencies revealed approximately twofold higher spontaneous mutant frequencies for spleen and liver of young adult (3-month-old) Apex+/ mice compared to those of Apex+/+ controls of the same age. The effects of an inactivated Apex allele were exacerbated with increased age, such that the spontaneous mutant frequencies in spleen and liver of 9-month-old Apex+/ mice were approximately doubled for each tissue. These data indicate that inactivation of one Apex allele results in cells with reduced protection against mutagenesis, possibly emanating from AP sites.
In stark contrast to somatic tissue from 3-month-old mice, spermatogenic cells obtained from 3-month-old Apex+/ lacI+ mice did not display an increased mutant frequency compared to that of Apex+/+ lacI+ mice of the same age. There are several possible explanations. (i) The abundance of BER proteins and in vitro BER activity is lower in tested somatic tissue compared to that of testis or spermatogenic cell types (7, 24, 42). Reduced Apex in somatic tissues may then compromise the inherently lower BER activity in somatic tissues. Indeed, while this study was under review, Raffoul et al. (48) reported decreased BER activity for liver nuclear extracts obtained from independently generated Apex+/ mice. Thus, the increased mutant frequency in somatic tissues is consistent with reduced in vitro BER activity for Apex+/ mice. (ii) AP sites do not occur as frequently in spermatogenic cells as in somatic cells. (iii) Other repair proteins and/or repair pathways compensate for the inactivated Apex allele in spermatogenic cells. (iv) The greater inherent expression of Apex in male germ cells is sufficient to accommodate the need for Apex in its various capacities even when one Apex allele is inactivated. Notably, Apex+/ mice display reduced in vitro BER activity in spermatogenic cell nuclear extracts obtained from young adult mice (25), indicating this is not likely. (v) Expression from the intact Apex allele may be enhanced in spermatogenic cells; however, the reduced BER activity in nuclear extracts prepared from Apex+/ mice (25) indicates this is unlikely. (vi) A higher frequency of apoptosis may occur in the germ cells and remove aberrant spermatogenic cells, thereby precluding a higher mutant frequency. However, the results of apoptosis prevalence in the testis of 3-month-old mice in the present study were not consistent with this possible explanation. (vii) Embryonic spermatogonia enter a mitotic arrest and reenter a mitotic cycle after birth (22, 44). In contrast, liver and spleen cells undergo continuous cell divisions until after birth. Both organs (liver and spleen) in the newborn continue to exhibit high cell division rates which slow down as the animals mature. The mitotic arrest experienced by spermatogenic cells may preclude an increased mutant frequency at 3 months of age. However, by 9 months of age the spermatogenic cells have undergone many more rounds of replication and therefore have had more opportunity to fix mutations.
Despite the mechanism that precluded a higher spontaneous mutant frequency in spermatogenic cells obtained from 3-month-old Apex+/ lacI+ mice, the mutant frequency was elevated in spermatogenic cells from 9-month-old mice. The increase was approximately twofold compared to that of Apex+/+ lacI+ mice of the same age. These data provide strong evidence that inactivation of an Apex allele is sufficient to result in an increased spontaneous mutant frequency in the male germ line, and they support the hypothesis that reduced Apex abundance in spermatogenic cells from old mice contributes to the reduced BER activity observed for nuclear extracts prepared from these cell types (25) and for the increased spontaneous mutant frequency at old ages (60). These data are also consistent with increased spontaneous mutagenesis observed in yeast after inactivation of the major AP endonuclease, APN1 (49).
The increased frequencies of mutants for somatic tissues obtained from Apex+/ mice and reported herein are consistent with reduced Apex mediating genomic instability. As reported by Raffoul et al. (48), Apex+/ mice display reduced BER activity in nuclear extracts prepared from liver. However, the data from a previous study (25) and the present study are incongruent with the testis results presented by Raffoul et al. (48). Their data show an increased abundance of DNA polymerase ß and increased BER in testis nuclear extracts prepared from Apex+/ mice compared to levels for wild-type mice. Notably, however, the BER activity reported for testis of Apex+/ and wild-type mice was lower than the level of liver BER activity (48). Apex abundance was similar in testis of wild-type mice and liver in one set of presented data. Thus, the testis data reported by Raffoul et al. (48) are inconsistent with results from previous reports (7, 24, 42). These differences between studies might have been caused by different experimental approaches. For example, the nuclear extracts prepared by Raffoul et al. (48) were prepared from frozen tissue. The extracts prepared for the studies reported by Intano et al. (24, 25) were prepared from fresh tissue or cell preparations. It seems possible that the content of the nuclear extracts was different in the various studies due to the different preparation methods.
While the increased mutant frequency observed in Apex+/ lacI+ mice is consistent with the scenario just presented, it is important to consider that Apex is a multifunctional protein. It is not, therefore, clear that the increased spontaneous mutant frequency detected in Apex+/ lacI+ mice is due exclusively to decreased BER. Indeed, changes in apoptosis prevalence might have a significant effect on mutant frequency. Apoptosis is thought to be activated when cells realize intolerable levels of DNA damage (6). Accordingly, it seemed possible that there would be elevated levels of apoptosis in Apex+/ mice, because AP sites can mediate a cytotoxic effect (12, 13, 51). The fraction of seminiferous tubule cross-sections with TUNEL-positive cells was significantly larger in samples from 9-month-old Apex+/ mice than in 9-month-old Apex+/+ mice. This increased prevalence of apoptotic cells may reflect a response to increased levels of DNA damage due to inactivation of one Apex allele. However, the increased prevalence of apoptosis is not sufficient to prevent an increased mutant frequency. Apex activation of p53 can lead to apoptosis in somatic cells (16). With reduced Apex, such as that in Apex+/ mice (34, 48), one would expect a reduction in p53-mediated apoptosis (16). At present, it is not clear that the observed apoptosis in pachytene spermatocytes of Apex+/ mice is mediated by p53. However, among spermatogenic cell types, p53 expression appears most robust in pachytene spermatocytes (53) and p53 is involved in ionizing radiation-induced apoptosis in spermatogenic cells (53).
Essentially all cell types scored TUNEL positive in the testis were spermatogonia or primary spermatocytes, and this is in agreement with other studies (2, 37). The relative proportions of apoptotic spermatogonia and primary spermatocytes were assessed to determine if one cell type was more prone to apoptosis in the Apex+/ mice. A larger fraction of the apoptotic cells were primary spermatocytes (54%) in the seminiferous tubule cross-sections prepared from 9-month-old Apex+/ mice, whereas apoptotic spermatogonia were less abundant (39%). No differences in the relative proportions of spermatogonia (20%) and primary spermatocytes (17%) was observed for seminiferous tubule cross-sections prepared from 9-month-old Apex+/+ mice. These results suggest that primary spermatocytes are more susceptible to apoptosis in Apex+/ mice. Interestingly, primary spermatocytes are more robustly affected by a decreased abundance of apoptosis in p53/ mice (66). The role of p53 in mediating apoptosis in spermatogenic cells in the environment of reduced Apex is not known.
Apoptosis in spermatogenic cells can be mediated by intrinsic or extrinsic signals (46). The process of apoptosis is essential to successful spermatogenesis. The essentiality of apoptosis has been demonstrated in mouse models in which apoptosis is defective (50). Spermatogenesis is severely impaired in these models. The amount of apoptosis varies in the process of spermatogenesis, with peaks of apoptosis occurring embryonically and during the first wave of spermatogenesis after birth (10, 37). Fluctuations in apoptosis prevalence vary in the adult animal (3, 27), although the cause for such fluctuations is not known.
Raffoul et al. (48) suggest that the effects they detected in Apex+/ mice are due to the redox function of Apex in part because addition of 100 ng of purified recombinant human AP endonuclease (APE) did not restore the BER activity in 50 µg of liver nuclear extracts prepared from Apex+/ mice. However, a previous study showed that addition of purified recombinant APE, in amounts of 1.25, 2.5, 5, 10, and 20 ng, did restore BER activity in freshly prepared mixed spermatogenic cell nuclear extracts obtained from Apex+/ mice (25). Once again, differences in experimental conditions may account for the differences in results. However, in neither case was the redox function of Apex tested directly; rather, the effects of changes in Apex abundance were tested. Multiple Apex functions possibly contribute to the various phenotypic effects observed in Apex+/ mice.
In summary, the data presented here support the hypothesis that inactivation of an Apex allele results in increased spontaneous mutant frequencies in somatic tissues and spermatogenic cells. In somatic tissues the genomic instability effect mediated by inactivation of one Apex allele is realized at a very young age, i.e., by 3 months of age. Genetic instability is greater in somatic tissues by 9 months of age. In comparison, genetic instability is delayed in spermatogenic cells but is observed at the still relatively young age of 9 months. Apoptosis is enhanced among spermatogenic cells in 9-month-old Apex+/ mice, particularly among primary spermatocytes, but the amount of apoptosis is insufficient to prevent an increased mutant frequency. The contributions of various Apex functions to genomic stability remain to be determined directly, and it will also be important to determine if reduced BER activity in and of itself is sufficient to mediate genomic instability in the male germ line.
| ACKNOWLEDGMENTS |
|---|
The views presented are the responsibility of the authors and are not necessarily those of the NIH or VHCS.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Allan, D. J., B. V. Harmon, and J. F. R. Kerr. 1987. Cell death in spermatogenesis, p. 229-259. In C. S. Potter (ed.), Perspectives on cell death. Oxford University Press, New York, N.Y.
3. Barnes, C. J., B. W. Covington, IV, I. L. Cameron, and M. Lee. 1998. Effect of aging on spontaneous and induced mouse testicular germ cell apoptosis. Aging-Clin. Exp. Res. 10:497-501.
4. Bellve, A. R. 1993. Purification, culture, and fractionation of spermatogenic cells. Methods Enzymol. 225:84-113.[Medline]
5. Bellve, A. R., J. C. Cavicchia, C. F. Millette, D. A. O'Brien, Y. M. Bhatnagar, and M. Dym. 1977. Spermatogenic cells of the prepuberal mouse. J. Cell Biol. 74:68-85.
6. Bernstein, C., H. Bernstein, C. M. Payne, and H. Garewal. 2002. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511:145-178.[CrossRef][Medline]
7. Cabelof, D. C., J. J. Raffoul, S. Yanamadala, C. Ganir, Z. M. Guo, and A. R. Heydari. 2002. Attenuation of DNA polymerase ß-dependent base excision repair and increased DMS-induced mutagenicity in aged mice. Mutat. Res. 500:135-145.[Medline]
8. Carlson, K. M., J. Bracamontes, C. E. Jackson, R. Clark, A. Lacroix, S. A. Wells, Jr., and P. J. Goodfellow. 1994. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am. J. Hum. Genet. 55:1076-1082.[Medline]
9. Chen, J., A. E. Tomkinson, W. Ramos, Z. B. Mackey, S. Danehower, C. A. Walter, R. A. Shultz, J. M. Besterman, and I. Husain. 1995. Mammalian DNA ligase III: molecular cloning, chromosomal location, and expression in spermatocytes undergoing meiotic recombination. Mol. Cell. Biol. 15:5412-5422.[Abstract]
10. Coucouvanis, E. C., S. W. Sherwood, Carswell-C. Crumpton, E. G. Spack, and P. P. Jones. 1993. Evidence that the mechanism of prenatal germ cell death in the mouse is apoptosis. Exp. Cell Res. 209:238-247.[CrossRef][Medline]
11. Crow, J. F. 2000. The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 1:40-46.[Medline]
12. Demple, B., and L. Harrison. 1994. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 63:915-948.[CrossRef][Medline]
13. Evans, A. R., M. Limp-Foster, and M. R. Kelley. 2000. Going APE over ref-1. Mutat. Res. 461:83-108.[Medline]
14. Francke, U., J. Felsenstein, S. M. Gartler, B. R. Migeon, J. Dancis, J. E. Seegmiller, F. Bakay, and W. L. Nyhan. 1976. The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am. J. Hum. Genet. 28:123-137.[Medline]
15. Friedberg, E. C., G. C. Walker, and W. Siede. 1995. DNA repair and mutagenesis. ASM Press, Washington, D.C.
16. Gaiddon, C., N. C. Moorthy, and C. Prives. 1999. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J. 18:5609-5621.[CrossRef][Medline]
17. Gravrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
18. Haldane, J. B. S. 1935. The rate of spontaneous mutation of a human gene. J. Genet. 31:317-326.
19. Haldane, J. B. S. 1947. The mutation rate of the gene for haemophilia, and its segregation ratios in males and females. Ann. Eugen. 13:262-271.
20. Hill, K. A., V. L. Buettner, B. W. Glickman, and S. S. Sommer. 1999. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat. Res. 436:11-19.[CrossRef][Medline]
21. Hill, K. A., H. Nishino, V. L. Buettner, A. Halangoda, S. Li, and S. S. Sommer. 1999. The Big Blue transgenic mouse mutation detection assay: the mutation pattern of sectored mutant plaques. Mutat. Res. 425:47-54.[Medline]
22. Hilscher, B., W. Hilscher, B. Bulthoff-Phnolz, U. Krämer, A. Birke, H. Pelzer, and G. Gauss. 1974. Kinetics of gametogenesis. I. Comparative histological and autoradiographic studies of oocytes and transitional prospermatogonia during oogenesis and prespermatogenesis. Cell Tissue Res. 154:443-470.[Medline]
23. Hirose, F., Y. Hotta, M. Yamaguchi, and A. Matsukage. 1989. Difference in the expression level of DNA polymerase ß among mouse tissues: high expression in the pachytene spermatocytes. Exp. Cell Res. 181:169-180.[CrossRef][Medline]
24. Intano, G. W., C. A. McMahan, R. B. Walter, J. R. McCarrey, and C. A. Walter. 2001. Mixed spermatogenic germ cell nuclear extracts exhibit high base excision repair. Nucleic Acids Res. 29:1366-1372.
25. Intano, G. W., C. A. McMahan, J. R. McCarrey, R. B. Walter, A. E. McKenna, Y. Matusmoto, M. A. MacInnes, D. J. Chen, and C. A. Walter. 2002. Base excision repair is limited by different proteins in male germ cell nuclear extracts prepared from young and old mice. Mol. Cell. Biol. 22:2410-2418.
26. Kohler, S. W., G. S. Provost, A. Fieck, P. L. Kretz, W. O. Bullock, J. A. Sorge, D. L. Putman, and J. M. Short. 1991. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA 88:7958-7962.
27. Kojima, S., H. Masahiko, S. Okada, T. Dukuda, Y. Toyama, S. Yuasa, H. Ito, and T. Tokuhisa. 2001. Testicular germ cell apoptosis in Bcl6-deficient mice. Development 128:57-65.[Abstract]
28. Jayaraman, L. J., K. G. K. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558-570.
29. Lindahl, T. 2000. Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. Mutat. Res. 462:129-135.[CrossRef][Medline]
30. Lindahl, T., and B. Nyberg. 1972. Rate of depurination of native deoxyribonucleic acid. Biochemistry 11:3610-3618.[CrossRef][Medline]
31. Loeb, L. A., and B. D. Preston. 1986. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 20:201-230.[CrossRef][Medline]
32. Ludwig, D. L., M. A. MacInnes, Y. Takiguchi, P. E. Purtymun, M. Henrie, M. Flanner, J. Meneses, R. A. Pedersen, and D. J. Chen. 1998. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 409:17-29.[Medline]
33. Mackey, Z. B., W. Ramos, D. S. Levin, C. A. Walter, J. R. McCarrey, and A. E. Tomkinson. 1997. An alternative splicing event which occurs in mouse pachytene spermatocytes generates a form of DNA ligase III with distinct biochemical properties that may function in meiotic recombination. Mol. Cell. Biol. 17:989-998.[Abstract]
34. Meira, L. B., S. Devaraj, G. E. Kisby, D. K. Burns, R. L. Daniel, R. E. Hammer, S. Grundy, I. Jialal, and E. C. Friedberg. 2001. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res. 61:5552-5557.
35. Memisoglu, A., and L. Samson. 2000. Base excision repair in yeast and mammals. Mutat. Res. 451:39-51.[Medline]
36. Moloney, D. M., S. F. Slaney, M. Oldridge, S. A. Wall, P. Sahlin, G. Stenman, and A. O. M. Wilkie. 1996. Exclusive paternal origin of new mutations in Apert syndrome. Nat. Genet. 13:48-53.[CrossRef][Medline]
37. Mori, C., N. Nakamura, D. J. Dix, M. Fujioka, S. Nakagawa, K. Shiota, and E. M. Eddy. 1997. Morphological analysis of germ cell apoptosis during postnatal testis development in normal and Hsp70-2 knockout mice. Dev. Dyn. 208:125-136.[CrossRef][Medline]
38. Nakamura, J., and J. A. Swenberg. 1999. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 59:2522-2526.
39. Nilsen, H., and H. E. Krokan. 2001. Base excision repair in a network of defense and tolerance. Carcinogenesis 22:987-998.
40. Nishino, H., V. L. Buettenr, and S. S. Sommer. 1996. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutation spectrum of ex vivo pinpoint mutant plaques. Mutat. Res. 372:97-105.[CrossRef][Medline]
41. Norbury, C. J., and I. A. Hickson. 2001. Cellular responses to DNA damage. Annu. Rev. Pharmacol. Toxicol. 41:367-401.[CrossRef][Medline]
42. Olsen, A.-K., H. Bjortuft, R. Wiger, J. A. Holme, E. C. Seeberg, M. Bjoras, and G. Brunborg. 2001. Highly efficient base excision repair (BER) in human and rate male germ cells. Nucleic Acids Res. 29:1781-1790.
43. Paashuis-Lew, Y., X. B. Zhang, and J. A. Heddle. 1997. On the origin of spontaneous mutations and sectored plaques detected in transgenic mice. Mutat. Res. 373:277-284.[Medline]
44. Peters, H. 1970. Migration of gonocytes into the mammalian gonad and their differentiation. Phil. Trans. R. Soc. Lond. B. 259:91-101.[Medline]
45. Piegorsch, W. W., B. H. Margolin, M. D. Shelby, A. Johnson, J. E. French, R. W. Tennant, and K. R. Tindall. 1995. Study design and sample sizes for a lacI transgenic mouse mutation assay. Environ. Mol. Mutagen. 25:231-245.[Medline]
46. Print, C. G., and K. L. Loveland. 2000. Germ cell suicide: new insights into apoptosis during spermatogenesis. BioEssays 22:423-430.[CrossRef][Medline]
47. Provost, G. S., and J. M. Short. 1994. Characterization of mutations induced by ethylnitrosourea in seminiferous tubule germ cells of transgenic B6D3F1 mice. Proc. Natl. Acad. Sci. USA 91:6564-6568.
48. Raffoul, J. J., D. C. Cabelof, J. Nakamura, L. B. Meira, E. C. Friedberg, and A. R. Heydari. 2004. Apurinic/apyrimidinic endonuclease (APE/REF-1) haploinsufficient mice display tissue-specific differences in DNA polymerase ß-dependent base excision repair. J. Biol. Chem. 279:18425-18433.
49. Ramotar, D., S. C. Popoff, E. B. Gralla, and B. Demple. 1991. Cellular role of yeast Apn 1 apurinic endonuclease/3'-diesterase: repair of oxidative and alkylation DNA damage and control of spontaneous mutation. Mol. Cell. Biol. 11:4537-4544.
50. Rodriguez, I., C. Ody, K. Araki, I. Garcia, and P. Vassalli. 1997. An early and massive of germinal cell apoptosis is required for the development of normal spermatogenesis. EMBO J. 16:2262-2270.[CrossRef][Medline]
51. Schaaper, R. M., T. A. Kunkel, and L. A. Loeb. 1983. Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc. Natl. Acad. Sci. USA 80:487-491.
52. Schuffenecker, I., N. Ginet, D. Goldgar, C. Eng, B. Chambe, A. Boneu, C. Houdent, D. Pallo, M. Schlumberger, C. Thivolet, and G. M. Lenoir. 1997. Prevalence and paternal origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Am. J. Hum. Genet. 60:233-237.[Medline]
53. Schwartz, D., N. Goldfinger, and V. Rotter. 1993. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8:1487-1494.[Medline]
54. Stuart, G. R., N. J. Gorelick, J. L. Andrews, J. B. DeBoer, and B. W. Glickman. 1996. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice. Environ. Mol. Mutagen. 28:385-392.[CrossRef][Medline]
55. Vogel, F., and R. Rathenberg. 1975. Spontaneous mutation in man. Adv. Hum. Genet. 4:223-318.
56. Walker, L. J., C. N. Robson, E. Black, D. Gillespie, and I. D. Hickson. 1993. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol. Cell. Biol. 13:5370-5376.
57. Walter, C. A., D. Nasr-Schirf, and V. J. Luna. 1989. Identification of transgenic mice carrying the CAT gene with PCR amplification. BioTechniques 7:1065-1070.[Medline]
58. Walter, C. A., D. A. Trolian, M. B. McFarland, K. A. Street, G. R. Gurram, and J. R. McCarrey. 1996. Xrcc-1 expression during male meiosis in the mouse. Biol. Reprod. 55:630-635.[Abstract]
59. Walter, C. A. 1999. Transgenic manipulation of the mouse genome, p. 387-415. In B. P. Yu (ed.), Methods in aging research. CRC Press, New York, N.Y.
60. Walter, C. A., G. W. Intano, J. R. McCarrey, C. A. McMahan, and R. B. Walter. 1998. Mutation frequency declines during spermatogenesis in young mice but increases in old mice. Proc. Natl. Acad. Sci. USA 95:10015-10019.
61. Walter, C. A., J. Lu, M. Bhakta, Z.-Q. Zhou, L. H. Thompson, and J. R. McCarrey. 1994. Testis and somatic Xrcc-1 DNA repair gene expression. Som. Cell Mol. Genet. 20:451-461.[CrossRef][Medline]
62. Wilson, D. M., III, and D. Barsky. 2001. The major human abasic endonuclease: formation, consequences, and repair of abasic lesions in DNA. Mutat. Res. 485:283-307.[Medline]
63. Xanthoudakis, S., and T. Curran. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA binding activity. EMBO J. 11:653-665.[Medline]
64. Xanthoudakis, S., G. Miao, F. Wang, Y. C. Pan, and T. Curran. 1992. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11:3323-3335.[Medline]
65. Xanthoudakis, S., G. G. Miao, and T. Curran. 1994. The redox and DNA repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. USA 91:23-27.
66. Yin, Y., B. C. Stahl, W. C. DeWolf, and A. Morgentaler. 1998. p53-mediated germ cell quality control in spermatogenesis. Dev. Biol. 204:165-171.[CrossRef][Medline]
67. Zhou, Z.-Q., and C. A. Walter. 1995. Expression of the DNA repair gene XRCC1 in baboon tissues. Mutat. Res. 348:111-116.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|